Follow-up from the A041202 study shows continued efficacy of ibrutinib regimens for older adults with CLL
A041202 研究的后续结果显示,伊布替尼治疗方案对老年慢性淋巴细胞白血病 (CLL) 患者持续有效。
期刊:Blood
影响因子:23.1
doi:10.1182/blood.2023021959
Woyach, Jennifer A; Perez Burbano, Gabriela; Ruppert, Amy S; Miller, Cecelia; Heerema, Nyla A; Zhao, Weiqiang; Wall, Anna; Ding, Wei; Bartlett, Nancy L; Brander, Danielle M; Barr, Paul M; Rogers, Kerry A; Parikh, Sameer A; Stephens, Deborah M; Brown, Jennifer R; Lozanski, Gerard; Blachly, James; Nattam, Sreenivasa; Larson, Richard A; Erba, Harry; Litzow, Mark; Luger, Selina; Owen, Carolyn; Kuzma, Charles; Abramson, Jeremy S; Little, Richard F; Dinner, Shira; Stone, Richard M; Uy, Geoffrey; Stock, Wendy; Mandrekar, Sumithra J; Byrd, John C